Abstract
Background
Ankylosing spondylitis (AS) is characterised by insidious onset lower back pain. Poor symptom recognition results in delays in diagnosis of up to 11 years. Despite the widespread use of anti-tumour necrosis factor alpha (anti-TNFα) therapy, work disability remains a challenging problem in AS.
Methods
A retrospective review of AS patients attending our physiotherapy service was carried out. Data regarding patient demographics, delay in diagnosis, treatment and disease activity were recorded.
Results
Ninety-two patients were identified of which 80 % were male. Just over 60 % of patients were on treatment with a TNF inhibitor and the average delay in diagnosis was 6 years. Clinically relevant changes in disease activity after 3 months of anti-TNFα therapy were demonstrated with a reduction in Bath AS Metrology Index, Bath AS Functional Index and Bath AS Disease Activity Index of 1, 1.99 and 2.39, respectively. In patients under the age of 65 years only 55.4 % of patients were employed. There was no relationship identified between diagnostic delay, employment status and treatment with an anti-TNF agent.
Conclusions
Delays in diagnosis of AS remain unacceptably high; however, delays of 6 years compare favourably to reported data. Despite this and the appropriate use of anti-TNFα agents, we continue to see high rates of unemployment in this patient group which can impact both on the person and society and bears further consideration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554–560
Hill JC, Whitehurst DG, Lewis M et al (2011) Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet 378(9802):1560–1571
Underwood MR, Dawes P (1995) Inflammatory back pain in primary care. Br J Rheumatol 34(11):1074–1077
Feldtkeller E, Khan MA, van der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66
Van der Linden S, van der Heijde D (1998) Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am 24(4):663–676
Hamilton L, Gilbert A, Skerrett J et al (2011) Services for people with ankylosing spondylitis in the UK-a survey of rheumatologists and patients. Rheumatol Oxf 50(11):1991–1998
Bakland G, Gran JT, Becker-Merok A et al (2011) Work disability in patients with ankylosing spondylitis in Norway. J Rheumatol 38(3):479–484
Kristensen LE, Petersson IF, Geborek P et al (2012) Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study. Rheumatol Oxf 51(2):243–249
Fabreguet I, Koumakis E, Burki V et al (2012) Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale. Rheumatol Oxf 51(2):333–337
Almodóvar R, Zarco P, Collantes E et al (2009) Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol 27(3):439–445
Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6):896–904
Van der Heijde D, Sieper J, Maksymowych WP, Assessment of Spondylo Arthritis international Society et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70(6):905–908
Lee W, Reveille JD, Davis JC Jr et al (2007) Are there gender differences in severity of ankylosing spondylitis? results from the PSOAS cohort. Ann Rheum Dis 66(5):633–638
Vander Cruyssen B, Ribbens C, Boonen A et al (2007) The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis 66(8):1072–1077
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sullivan, C., Quinn, K., Harney, S. et al. The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay. Ir J Med Sci 183, 579–584 (2014). https://doi.org/10.1007/s11845-013-1054-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-013-1054-3